Corporate Banner
Satellite Banner
qPCR
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

RainDance Attracts Top-Tier Commercial Leadership to Accelerate Global Growth

Published: Tuesday, May 21, 2013
Last Updated: Tuesday, May 21, 2013
Bookmark and Share
RainDance Technologies, Inc. has announced several high-profile additions to its commercial leadership team.

Industry veterans Jay Therrien, Ph.D., Roger Schaller, and Yafei Liu, Ph.D. have joined the company to further accelerate growth in the Digital PCR and Targeted Sequencing product areas. These hires complement the company’s global expansion of its service and support operations which are focused on enhancing the experience of its customers and accelerating customer adoption.

In April, RainDance announced the closing of a $20 million Series E financing as well as a multi-year commercial supply agreement with Myriad Genetics, which has adopted RainDance’s ThunderStorm™ system for its myRisk™ hereditary cancer panel. Last week, Myriad announced its plan to convert the hereditary cancer market by transitioning a significant share of their leading tests to myRisk by the summer of 2015. Initially the test will provide pan-cancer screening for breast, colon, ovarian, endometrial, pancreatic and melanoma – and in the future, lung, prostate, and all cancers.

“This is a breakthrough year for RainDance with recent successes in sequencing and the launch of the RainDrop™ digital PCR system positioning us to continue doubling sales annually for the next several years,” said Andy Watson, Chief Commercial Officer at RainDance. “We are thrilled to add the caliber and depth of sales experience that Jay, Roger and Yafei bring to driving adoption of disruptive genomic technologies. They will be instrumental in realizing our vision of transforming the early detection and screening of cancer and other inherited diseases.”

Jay Therrien, Ph.D., joins RainDance as Vice President of Worldwide Sales. He was previously Senior Vice President of Global Sales at Knome. Prior to Knome, Therrien was Vice President, Commercial Operations, Sequencing at Life Technologies, where he directed sales and support activities for Sanger capillary electrophoresis (CE), SOLiD™, and Ion Torrent sequencing franchises. He previously held sales leadership roles at Illumina including Director of Sales for the Asia-Pacific region and Japan. He has a B.S. from the University of Illinois at Urbana-Champaign and a Ph.D. from the University of Kansas.

Roger Schaller joins RainDance as Business Leader of Next-Generation Sequencing. He comes from Affymetrix, where he was Senior Director of Business Development for the Molecular Diagnostics business managing global partnerships in the “Powered by Affymetrix™” program. Previously, Schaller was Director of North American Sales and Marketing at Cepheid, where he was responsible for sales and market development, as well as building the company’s commercial teams. Schaller has also held business development, sales and marketing positions at Dade-Behring. He has a B.S. in medical technology and biology from Illinois State University.

Yafei Liu, Ph.D., joins as Head of Commercial Operations for the Asia-Pacific region. Prior to RainDance, Liu was responsible for Life Technologies’ China sales team selling digital PCR, sequencing, and quantitative PCR products. Liu also worked at Applied Biosystems for several years on the qPCR R&D team. Liu is based in Beijing.

“RainDance has built leading franchises in digital PCR and targeted sequencing that rival any other in innovative impact on research and translational medicine,” said Therrien. “We are all delighted to be joining this world-class team at a time when RainDance is experiencing a major inflection point in growth and customer adoption.”


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,000+ scientific posters on ePosters
  • More than 4,500+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Pacific Biosciences and RainDance Technologies Partner
Partnership combines Pacific Biosciences’ Single Molecule, Real-Time (SMRT®) Sequencing and informatics capabilities with RainDance’s proprietary digital droplet and single molecule barcoding technology.
Saturday, May 23, 2015
RainDance Technologies Extends Global Commercial Reach
BioTech-Europe, Diatech, Labgene Scientific, and Neo-Science embrace company’s award-winning droplet technology platform to meet growing demand for liquid biopsy research applications.
Friday, April 17, 2015
RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics
Patent infringement lawsuit filed in response to the sale of a system that infringes RainDance's patent rights.
Friday, February 13, 2015
RainDance Technologies Appoints Scott Bortner Vice President of Intellectual Property
Pioneer in droplet-based genetic analysis IP committed to expanding its foundational patent portfolio to advance novel liquid biopsy applications.
Thursday, January 22, 2015
RainDance Forms Hematologic Oncology Consortium
HemOnc experts validate unmet need and performance of new ThunderBolts Myeloid NGS Panel at ASH 2014.
Thursday, December 11, 2014
RainDrop Digital PCR System Named a Top 10 Innovation for 2014 by The Scientist
RainDance’s droplet-based platform can detect and monitor rare biomarkers for cancers, viruses, pathogens, and immune disorders with absolute precision to enable cell-free liquid biopsy research.
Monday, December 01, 2014
RainDance Appoints Martin M. Coyne II and Glenn P. Muir to Board of Directors
Executives bolster board expertise as Company expands its reach into leading genomics research labs by enabling non-invasive Fluid Biopsy™ applications.
Friday, November 07, 2014
HudsonAlpha Named Latest RainDance Center of Excellence
Premier biotech research center adopts complete RainDance product portfolio to enhance next-generation sequencing and digital PCR services offering.
Tuesday, October 28, 2014
RainDance Technologies Appoints John A. Luckey VP of Product Development
Biotechnology professional brings proven experience designing, developing and delivering products for life-science applications.
Tuesday, October 14, 2014
High-Throughput Targeted Sequencing of Cancer Predisposition Genes
British Columbia Cancer Agency selects Raindance’s new ThunderStorm System to aid researchers in hereditary cancer testing, using next-generation sequencing.
Friday, November 18, 2011
RainDance Technologies Names Andy Watson Vice President and Chief Marketing Officer
In this role, Mr. Watson will lead the company’s global marketing and strategy efforts to grow the current commercial targeted sequencing business and prepare the market for the launch of its digital PCR and single cell analysis products.
Wednesday, May 25, 2011
A Targeted Sequencing Approach Powers Three Groundbreaking Human Genetic Studies
Scientists from Leading Institutions to Present Data Demonstrating Impact of Technology in Organ Transplantation, Alzheimer’s, Autism and X-linked Mental Retardation Research.
Tuesday, November 30, 2010
Scientific News
Finding Zika One Paper Disc At A Time
A novel, inexpensive method for detecting the Zika virus could help slow spread of outbreak, and potentially other future pandemic diseases.
Rapid Diagnosis of Bacterial Infections
Mass. General-developed compact system could shorten diagnostic time from days to hours, bring testing to point of care.
Monovar Drills Down Into Cancer Genome
Rice, MD Anderson develop program to ID mutations in single cancer cells.
Biomarkers for Profiling Prostate Cancer Patients
Exiqon A/S has announced the publication of validation of prognostic microRNA biomarkers for the aggressiveness of prostate cancer in independent cohorts.
Gene Analysis System Could Accelerate Pace of Research on the Space Station
The WetLab-2 system will enable spaceflight genomic studies involving a wide variety of biospecimen types in the unique microgravity environment of space.
Liquid Biopsy for NSCLC
'Liquid biopsy' blood test accurately detects key genetic mutations in most common form of lung cancer, study finds.
Rare DNA Will Have Nowhere To Hide
Two National Institutes of Health grants back Rice University effort to develop new diagnostics.
Seeing Cell to Cell Differences
Seeing differences between individual cells for first time explains symptoms of rare genetic disorders, finds penn study.
Circular RNAs Implicated in Cancer
Circular RNAs – like their protein counterparts – are also affected by genomic rearrangements in cancer, resulting in abnormal fusions.
Know Thy Helicobacter pylori
Non-invasive method for genotyping H.pylori developed.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,000+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,500+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!